These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 1687219
1. Histamine, leukotriene D4 and platelet-activating factor in guinea pig passive cutaneous anaphylaxis. Weg VB, Watson ML, Cordeiro RS, Williams TJ. Eur J Pharmacol; 1991 Nov 05; 204(2):157-63. PubMed ID: 1687219 [Abstract] [Full Text] [Related]
2. Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats. Taira M, Kohno SW, Yamamura H, Ohata K. Agents Actions; 1988 Jun 05; 24(1-2):189-95. PubMed ID: 3407549 [Abstract] [Full Text] [Related]
3. Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin. Pedersen KE, Rigby PJ, Goldie RG. Br J Pharmacol; 1991 Sep 05; 104(1):128-32. PubMed ID: 1664758 [Abstract] [Full Text] [Related]
4. Investigation of the endogenous chemoattractants involved in 111In-eosinophil accumulation in passive cutaneous anaphylactic reactions in the guinea-pig. Weg VB, Watson ML, Faccioli LH, Williams TJ. Br J Pharmacol; 1994 Sep 05; 113(1):35-42. PubMed ID: 7812629 [Abstract] [Full Text] [Related]
5. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent. Levrier J, Duval D, Prouteau M, Voltz C, Berry CN, Lloyd KG, Scatton B. Arzneimittelforschung; 1995 May 05; 45(5):559-68. PubMed ID: 7541995 [Abstract] [Full Text] [Related]
6. Investigation of leukotriene involvement in the vasopermeability response associated with guinea pig tracheal anaphylaxis: comparison with cutaneous anaphylaxis. Woodward DF, Wasserman MA, Weichman BM. Eur J Pharmacol; 1983 Sep 16; 93(1-2):9-19. PubMed ID: 6313400 [Abstract] [Full Text] [Related]
7. Evidence for distinct systemic extravasation effects of platelet activating factor, leukotrienes B4, C4, D4 and histamine in the guinea pig. Handley DA, Farley C, Deacon RW, Saunders RN. Prostaglandins Leukot Med; 1986 Mar 16; 21(3):269-77. PubMed ID: 3010331 [Abstract] [Full Text] [Related]
8. The effects of H1 and H2 receptor antagonism on the response of monkey skin to intradermal histamine, reverse-type anaphylaxis, and passive cutaneous anaphylaxis. Hutchcroft BJ, Moore EG, Orange RP. J Allergy Clin Immunol; 1979 Jun 16; 63(6):376-82. PubMed ID: 36420 [Abstract] [Full Text] [Related]
9. Effect of CV-3988, a specific antagonist against platelet activating factor, on homologous passive cutaneous anaphylaxis in the mouse ear. Inagaki N, Miura T, Ohira K, Nagai H, Xu QA, Koda A. J Pharmacobiodyn; 1990 May 16; 13(5):272-7. PubMed ID: 2177106 [Abstract] [Full Text] [Related]
10. Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether. Detsouli A, Lefort J, Vargaftig BB. Br J Pharmacol; 1985 Apr 16; 84(4):801-10. PubMed ID: 4005486 [Abstract] [Full Text] [Related]
11. The effects of combined histamine and platelet-activating factor antagonism on systemic anaphylaxis induced by immunoglobulin E in the rabbit. Lohman IC, Halonen M. Am Rev Respir Dis; 1993 May 16; 147(5):1223-8. PubMed ID: 8484635 [Abstract] [Full Text] [Related]
12. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist. Hwang SB, Li CL, Lam MH, Shen TY. Lab Invest; 1985 Jun 16; 52(6):617-30. PubMed ID: 3925239 [Abstract] [Full Text] [Related]
13. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs. Pretolani M, Lefort J, Malanchère E, Vargaftig BB. Eur J Pharmacol; 1987 Aug 21; 140(3):311-21. PubMed ID: 3653247 [Abstract] [Full Text] [Related]
14. Suppression of the Arthus reaction by Y-24180, a potent and specific antagonist of platelet-activating factor. Okamoto H, Iwahisa Y, Terasawa M. Agents Actions; 1992 Mar 21; 35(3-4):149-58. PubMed ID: 1388318 [Abstract] [Full Text] [Related]
15. Effect of Y-24180, a platelet-activating factor-receptor antagonist, on the antigen-induced airway microvascular leakage in guinea pigs. Iwahisa Y, Yamaguchi S, Kagoshima M, Terasawa M. Jpn J Pharmacol; 1996 Nov 21; 72(3):209-15. PubMed ID: 8957681 [Abstract] [Full Text] [Related]
16. Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis. Felix SB, Baumann G, Hashemi T, Niemczyk M, Ahmad Z, Berdel WE. J Cardiovasc Pharmacol; 1990 Jun 21; 15(6):987-97. PubMed ID: 1694923 [Abstract] [Full Text] [Related]
17. Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear. Inagaki N, Goto S, Yamasaki M, Nagai H, Koda A. Int Arch Allergy Appl Immunol; 1986 Jun 21; 80(3):285-90. PubMed ID: 3087885 [Abstract] [Full Text] [Related]
18. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin. Sanz MJ, Weg VB, Walsh DT, Williams TJ, Nourshargh S. Br J Pharmacol; 1994 Oct 21; 113(2):513-21. PubMed ID: 7834203 [Abstract] [Full Text] [Related]
19. Immediate inhibitory effect of methylprednisolone suleptanate (U-67590A) on antigen-induced cutaneous and airway anaphylactic responses in guinea-pigs. Hashimoto M, Shinozaki Y, Katori M. Br J Pharmacol; 1993 Mar 21; 108(3):604-12. PubMed ID: 7682130 [Abstract] [Full Text] [Related]
20. Leucotrienes, SRS-A and the vascular manifestations of PCA. Morley J, Page C, Paul W. Agents Actions; 1981 Dec 21; 11(6-7):585-7. PubMed ID: 6122355 [Abstract] [Full Text] [Related] Page: [Next] [New Search]